AEYE Comprehensive Screening (AEYE-CS)
AEYE Comprehensive Screening
AI-based diagnostic screening for a broad range of diseases using retinal images
CAUTION: Federal (US) law restricts this device to investigational use only.
NOT SOLD IN THE US
AEYE Comprehensive Screening utilizes AI technology to diagnose or predict the development of a broad range of diseases from retinal images. Current diseases diagnosed and/or predicted include diabetic retinopathy, glaucoma, AMD, diabetes, cataract, diabetic macular edema, cardiovascular disease, occlusion, and hypertension; and the list continues to grow.
The accuracy of disease detection or prediction is backed by studies on large data sets, and supported by rigorous statistical analyses.
The first practical point-of-care diagnostic screening for a wide range of diseases
How it works
A single image per eye is obtained using an indicated camera
Images are analyzed by the AI
Diagnoses are produced in under a minute
Benefits of Point-of-Care Comprehensive Screening
The first solution to require only 1 image per eye; rarely requires dilation
Diagnosis in under a minute